Trial Profile
Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif) in MS Patients. Case Series for Adjustment of Treatment Strategy and Its Monitoring.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck KGaA
- 14 Jun 2010 New trial record